Today’s news
Telix ProstACT Phase 3 Part 1 meets safety goals
Telix's TLX591-Tx combination therapy shows acceptable safety profile in mCRPC patients
Fred Hutch hematologists featured at 2026 Tandem Meetings
Fred Hutch scientists presented research on stem cell transplantation risks and gene expression changes during pre-transplant conditioning.
Castle Country Radio names PERKIE Travels as March Charity of the Month
The radiation transportation service helps hundreds of cancer patients in the region get to treatment.
